Tai, Yan
Wang, Chuan
Wang, Zhihua
Liang, Yi
Du, Junying
He, Dongwei
Fan, Xiaoyan
Jordt, Sven-Eric
Liu, Boyi
Article History
Received: 23 March 2017
Accepted: 30 June 2017
First Online: 8 August 2017
Competing Interests
: Dr. Sven-Eric Jordt serves on the Scientific Advisory Board of Hydra Biosciences LLC (Cambridge, MA), a biopharmaceutical company developing TRP ion channel inhibitors for the treatment of pain and inflammation. All other authors declare that they have no competing interests.